AstraZeneca
AZN
#50
Rank
NZ$485.38 B
Marketcap
NZ$313.10
Share price
-1.40%
Change (1 day)
33.44%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): NZ$10.22

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is NZ$10.05. In 2024 the company made an earnings per share (EPS) of NZ$7.69 an increase over its 2023 EPS that were of NZ$6.51.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$10.2232.81%
2024NZ$7.6918.23%
2023NZ$6.5181.13%
2022NZ$3.59631.03%
2021NZ$0.49-88.11%
2020NZ$4.14136.89%
2019NZ$1.75-39.41%
2018NZ$2.88-28.27%
2017NZ$4.02-14.37%
2016NZ$4.6924.11%
2015NZ$3.78127.55%
2014NZ$1.66-51.96%
2013NZ$3.46-58.95%
2012NZ$8.42-32.2%
2011NZ$12.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.88 87.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.20 21.42%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.30-77.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.36-36.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$39.02 288.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.50-65.17%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$14.97 48.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.39 23.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.86-41.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.39-36.46%๐Ÿ‡ฌ๐Ÿ‡ง UK